Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant FOLFOX6 and Short-Course Radiotherapy for Unresectable Rectal Cancer
NCT01269229Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Jan 2010
- Primary completion
- Apr 2015
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, fluorouracil, folinic acid in rectal cancer, liver metastases, sponsored by Yonsei University. Started Jan 2010; status: completed.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
rectal cancerliver metastases
Beyond the preview
Go deeper on NCT01269229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01269229.